fr

EN DE

fr

EN DE

Publications

2075 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2022

Molecules (Basel, Switzerland)

Emhemmed F

Extract Induces Apoptosis in Human Pancreatic 3D Cancer Models: Importance of Major Antioxidant Molecules Present Therein.

2022

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Eber J

Increased cardiac uptake of (18F)-fluorodeoxyglucose incidentally detected on positron emission tomography after left breast irradiation: How to interpret?

2022

The Lancet. Oncology

Thiery-Vuillemin A

Pain and health-related quality of life with olaparib versus physician's choice of next-generation hormonal drug in patients with metastatic castration-resistant prostate cancer with homologous recombination repair gene alterations (PROfound): an open-lab

2022

European journal of cancer (Oxford, England : 1990)

Brugel M

Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: A French comprehensive multicentre ambispective observational cohort study (CAPANCOVID).

2022

Hepatology international

Dana J

Conventional and artificial intelligence-based imaging for biomarker discovery in chronic liver disease.

2022

Journal francais d'ophtalmologie

Vuillemey L

[Corneal toxicity of mirvetuximab soravtansine: A case report].

2022

Cancers

Rhaiem R

Implications of RAS Mutations on Oncological Outcomes of Surgical Resection and Thermal Ablation Techniques in the Treatment of Colorectal Liver Metastases.

2022

Medicine

Godard F

Cerebellum/liver index in pretherapeutic 18F-FDG PET/CT as a predictive marker of progression-free survival in follicular lymphoma treated by immunochemotherapy and rituximab maintenance.

2022

Cancers

Schmitt M

The Impact of an Incidental Dose on Axillary Tumor Control and Toxicity in Localized Breast Cancer: A Retrospective Analysis.

2022

Nature medicine

Derosa L

Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer.